These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2852169)

  • 21. Japanese encephalitis vaccines.
    Wkly Epidemiol Rec; 1998 Oct; 73(44):337-44. PubMed ID: 9817024
    [No Abstract]   [Full Text] [Related]  

  • 22. Study of the outbreak of Japanese encephalitis in Lakhimpur district of Assam in 1989.
    Vajpayee A; Dey PN; Chakraborty AK; Chakraborty MS
    J Indian Med Assoc; 1992 May; 90(5):114-5. PubMed ID: 1325526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccines against Japanese encephalitis.
    Bhau LN; Saxena SN
    J Commun Dis; 1989 Mar; 21(1):75-80. PubMed ID: 2553796
    [No Abstract]   [Full Text] [Related]  

  • 24. Side-effects with Japanese encephalitis vaccine.
    Andersen MM; Rønne T
    Lancet; 1991 Apr; 337(8748):1044. PubMed ID: 1673198
    [No Abstract]   [Full Text] [Related]  

  • 25. Japanese encephalitis vaccine: necessary for the Olympics in Seoul?
    Steffen R
    N Engl J Med; 1988 Jul; 319(4):251. PubMed ID: 2839771
    [No Abstract]   [Full Text] [Related]  

  • 26. Field experiments on live attenuated Japanese encephalitis virus vaccine for swine.
    Ueba N; Kimura T; Nakajima S; Kurimura T; Kitaura T
    Biken J; 1978 Sep; 21(3):95-103. PubMed ID: 219844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children.
    Xin YY; Ming ZG; Peng GY; Jian A; Min LH
    Am J Trop Med Hyg; 1988 Aug; 39(2):214-7. PubMed ID: 2841880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunisation against Japanese encephalitis in Nepal: experience of 1152 subjects.
    Henderson A
    J R Army Med Corps; 1984 Oct; 130(3):188-91. PubMed ID: 6098647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis.
    Kumar R; Tripathi P; Rizvi A
    N Engl J Med; 2009 Apr; 360(14):1465-6. PubMed ID: 19339732
    [No Abstract]   [Full Text] [Related]  

  • 30. [Observations on the reactions following vaccination of the inactivated Japanese encephalitis virus vaccine from tissue culture (author's transl)].
    Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Mar; 15(2):98-100. PubMed ID: 7307821
    [No Abstract]   [Full Text] [Related]  

  • 31. A field study on Nakayama and Beijing strains of Japanese encephalitis vaccines.
    Nimmannitya S; Hutamai S; Kalayanarooj S; Rojanasuphot S
    Southeast Asian J Trop Med Public Health; 1995 Dec; 26(4):689-93. PubMed ID: 9139377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurological complications and Japanese encephalitis vaccination.
    Plesner AM; Arlien-Søborg P; Herning M
    Lancet; 1996 Jul; 348(9021):202-3. PubMed ID: 8684185
    [No Abstract]   [Full Text] [Related]  

  • 33. [Japanese encephalitis: vaccination for some travelers to Asia useful and possible in The Netherlands].
    Kager PA
    Ned Tijdschr Geneeskd; 1993 Aug; 137(35):1755-7. PubMed ID: 8396734
    [No Abstract]   [Full Text] [Related]  

  • 34. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
    Yang SE; Pan MJ; Tseng HF; Liau MY
    Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Determination of the optimal dose of a cultured inactivated vaccine for preventing Japanese encephalitis].
    Grachev VP; Sumarokov AA; Kharazian EG; Shkol'nik RIa; Karinskaia GA
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):98-103. PubMed ID: 6322486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse reactions to Japanese encephalitis vaccine.
    Ruff TA; Eisen D; Fuller A; Kass R
    Lancet; 1991 Oct; 338(8771):881-2. PubMed ID: 1681228
    [No Abstract]   [Full Text] [Related]  

  • 38. Japanese B encephalitis vaccine. Time for a reappraisal?
    Ruff TA
    Med J Aust; 1994 Oct; 161(8):511. PubMed ID: 7802832
    [No Abstract]   [Full Text] [Related]  

  • 39. [Levels of HI antibody against Japanese encephalitis virus and the effect of vaccination in inpatients of a tuberculosis sanatorium in Fukuoka City].
    Kusaba T; Ichiki T; Nagai K; Tachibana N; Matsumoto I
    Kansenshogaku Zasshi; 1972 Jul; 46(7):240-5. PubMed ID: 4347344
    [No Abstract]   [Full Text] [Related]  

  • 40. Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection.
    Pugachev KV; Mason PW; Shope RE; Frey TK
    Virology; 1995 Oct; 212(2):587-94. PubMed ID: 7571428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.